News
ACE BioSciences enzyme gets EU Orphan Drug Designation Approval
Zymenex in Phase 3 clinical trial in patients with the rare disease alpha-Mannosidosis

Frontpage statement 

Zymenex A/S Roskildevej 12 C
3400 Hillerød, DK
Tel  +45 48250054
Fax  +45 48251054
Affiliate Sweden Agavägen 58
181 55 Lidingö, S
Tel  +46 8 7670203
Fax  +46 8 7670233

© 2004 Zymenex A/S